Trials / Completed
CompletedNCT00770666
Combination Medications vs. Patch Alone for Medically-Ill Smokers
Flexibly-Dosed Combination Pharmacotherapy Versus Standard-Dosed Nicotine Patch Alone for Smokers With Medical Illness
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 127 (actual)
- Sponsor
- University of Medicine and Dentistry of New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized clinical trial to evaluate a flexibly-dosed-3-medication combination for up to 6 months in smokers with medical illness
Detailed description
Subjects randomly received either nicotine patch alone for a 10-week, tapering course (n=64) or the combination of nicotine patch, nicotine oral inhaler, and bupropion for an ad-lib duration (n=63).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicotine patch, nicotine inhaler, bupropion | Patch - 21 mg - taper as able Inhaler - as needed Bupropion SR 150 mg daily |
| DRUG | Nicotine patch | 21 mg daily for 6 weeks followed by 14 mg for 2 weeks and then 7 mg for 2 weeks |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2007-12-01
- Completion
- 2008-01-01
- First posted
- 2008-10-10
- Last updated
- 2008-10-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00770666. Inclusion in this directory is not an endorsement.